INO
INO
NASDAQ · Biotechnology

Inovio Pharmaceuticals Inc

Penny Stocks Biotech Stocks Healthcare Stocks
$1.66
+0.10 (+6.41%)
As of Feb 8, 2:10 PM ET ·
Analyst Consensus
Buy
10
Analysts
Moderate
Coverage
Buy 7 70%
Hold 3 30%
Sell 0 0%
Price Target
Analyst Price Target +1,081.3% upside
Low Target $14.26
Average Target $19.61
High Target $29.32
Current Price $1.66
Current
$1.66
Target
$19.61
$14.26 $19.61 avg $29.32
Scenario Analysis
Bear Case
$14.26
759.0%
Low target
Base Case
$19.61
+1,081.3%
Avg target
Bull Case
$29.32
+1,666.3%
High target
Risk/Reward
2.2x
Favorable
Price in Context
52-Week High
$25.72
-93.5% from high
52-Week Low
$14.02
+-88.2% from low
Target vs 52W High
$19.61
-23.8% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Buy 37 68% $257.58 +15.3%
AMGN
Amgen Inc
 Hold 41 54% $190.87 -50.3%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +137.8%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 77% $438.34 -8.3%
REGN
Regeneron Pharmaceuticals
 Strong Buy 36 75% $76.80 -90.2%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 75% $102.31 -68.8%
INSM
Insmed Inc
 Strong Buy 27 93% $143.40 -4.3%
BIIB
Biogen Inc
 Hold 42 48% $91.45 -54.5%